Pharma and Biotech
Licensing and Partnership MoU for North America | 02-Apr-2024 | 07:00 | RNS |
Placing to raise £0.62 million | 26-Mar-2024 | 07:00 | RNS |
Interim Results | 28-Sep-2023 | 07:00 | RNS |
Update on Put Option with Conduit | 21-Sep-2023 | 07:00 | RNS |
Completion of Evaluation Programme with Bio-Techne | 19-Sep-2023 | 07:00 | RNS |
Extension of and update on Put Option with Conduit | 08-Sep-2023 | 07:03 | RNS |
Update on Put Option with Conduit | 15-Aug-2023 | 07:00 | RNS |
Expansion of Research Agreement and CIZ1B Update | 10-Aug-2023 | 07:00 | RNS |
Total Voting Rights | 30-Jun-2023 | 17:00 | RNS |
Result of AGM | 28-Jun-2023 | 12:01 | RNS |
Total Voting Rights | 12-Jun-2023 | 14:15 | RNS |
Subscription to raise £350,000 | 12-Jun-2023 | 07:00 | RNS |
Posting of Annual Report and Notice of AGM | 05-Jun-2023 | 12:35 | RNS |
Update on Royalty Sharing Agreement in AZD1656 | 15-May-2023 | 13:42 | RNS |
Results for the year ended 31 December 2022 | 27-Apr-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 1.63p |
Change Today | -0.025p |
% Change | -1.52 % |
52 Week High | 3.65 |
52 Week Low | 1.63 |
Volume | 72,500 |
Shares Issued | 396.39m |
Market Cap | £6.44m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
08:30 | 52,500 @ 1.66p |
08:12 | 20,000 @ 1.70p |
Finance Director | Nigel Ronald Lee |
You are here: research